NKTR: Nektar Therapeutics Stocks News on April 19, 2025

Jefferies Upgrades Nektar Therapeutics to Buy, Doubles Price Target to $2.00

NKTR

GuruFocus.com

8 days ago

Jefferies Upgrades Nektar Therapeutics to Buy, Doubles Price Target to $2.00

NKTR

MT Newswires

8 days ago

Nektar Therapeutics Shares Rise After Upgrade From Jefferies

NKTR

Zacks

8 days ago

Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?

NKTR

MT Newswires

8 days ago

Jefferies Upgrades Nektar Therapeutics to Buy From Hold, Adjusts Price Target to $2 From $1

NKTR

MT Newswires

22 days ago

Nektar Therapeutics Files $300 Million Mixed Shelf

NKTR

Insider Monkey

a month ago

Nektar Therapeutics (NKTR): Among Stocks Wall Street Is Calling Bullish Amid Market Turmoil

Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

NKTR

PR Newswire

a month ago

Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference

NKTR

MT Newswires

a month ago

Nektar Therapeutics Shares Rise After Upgrade From Oppenheimer

NKTR

Zacks

a month ago

Nektar Therapeutics (NKTR) Q4 Earnings Miss Estimates (Revised)

NKTR

MT Newswires

a month ago

Oppenheimer Upgrades Nektar Therapeutics to Outperform From Market Perform, Price Target is $6

Nektar Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

NKTR

Simply Wall St.

a month ago

Nektar Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Nektar Q4 Loss Wider Than Expected, Pipeline in Focus, Stock Up

NKTR

Zacks

a month ago

Nektar Q4 Loss Wider Than Expected, Pipeline in Focus, Stock Up

NKTR

Thomson Reuters StreetEvents

a month ago

Q4 2024 Nektar Therapeutics Earnings Call

NKTR

GuruFocus.com

a month ago

Nektar Therapeutics (NKTR) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

NKTR

Zacks

a month ago

Nektar (NKTR) Reports Q4 Earnings: What Key Metrics Have to Say

NKTR

Zacks

a month ago

Nektar Therapeutics (NKTR) Q4 Earnings Beat Estimates

NKTR

Associated Press Finance

a month ago

Nektar: Q4 Earnings Snapshot

Assertio (ASRT) Reports Q4 Loss, Tops Revenue Estimates

NKTR

Zacks

a month ago

Assertio (ASRT) Reports Q4 Loss, Tops Revenue Estimates

Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

NKTR

PR Newswire

a month ago

Nektar Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

NKTR

PR Newswire

a month ago

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2024 on Wednesday, March 12, 2025, After Close of U.S.-Based Financial Markets

Nektar completes enrolment in trial of rezpegaldesleukin for alopecia areata

NKTR

Clinical Trials Arena

2 months ago

Nektar completes enrolment in trial of rezpegaldesleukin for alopecia areata

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

NKTR

PR Newswire

2 months ago

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AA Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Severe-to-Very Severe Alopecia Areata

NKTR

MT Newswires

2 months ago

Nektar Therapeutics Partners With TrialNet to Test Rezpegaldesleukin in Type 1 Diabetes

Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

NKTR

PR Newswire

2 months ago

Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus

Nektar Therapeutics to Host Virtual Investor & Analyst Event with Type 1 Diabetes Experts on February 24th

NKTR

PR Newswire

2 months ago

Nektar Therapeutics to Host Virtual Investor & Analyst Event with Type 1 Diabetes Experts on February 24th

NKTR

MT Newswires

2 months ago

Nektar Says FDA Grants Fast-Track Designation to Atopic Dermatitis Treatment

Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

NKTR

PR Newswire

2 months ago

Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Moderate-to-Severe Atopic Dermatitis

NKTR

Zacks

2 months ago

Down -38.51% in 4 Weeks, Here's Why Nektar (NKTR) Looks Ripe for a Turnaround

NKTR

Zacks

3 months ago

Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol

NKTR

Zacks

3 months ago

Nektar (NKTR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era

NKTR

Zacks

3 months ago

5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era

MediWound (MDWD) Surges 8.5%: Is This an Indication of Further Gains?

NKTR

Zacks

3 months ago

MediWound (MDWD) Surges 8.5%: Is This an Indication of Further Gains?

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis

NKTR

PR Newswire

3 months ago

Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial of Rezpegaldesleukin in Patients with Moderate-to-Severe Atopic Dermatitis

NKTR

MT Newswires

3 months ago

B. Riley Starts Nektar Therapeutics With Buy Rating, $4 Price Target

NKTR

Insider Monkey

3 months ago

Why Nektar Therapeutics (NKTR) Is Among the Best Penny Stocks to Invest In According to Media?

NKTR

Simply Wall St.

3 months ago

Institutional investors have a lot riding on Nektar Therapeutics (NASDAQ:NKTR) with 68% ownership

NKTR

MT Newswires

4 months ago

HC Wainwright Initiates Nektar Therapeutics at Buy With $6.50 Price Target

$Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting$

NKTR

PR Newswire

4 months ago

Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting

NKTR

PR Newswire

5 months ago

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence

NKTR

Simply Wall St.

5 months ago

Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets

Nektar Therapeutics Third Quarter 2024 Earnings: Beats Expectations

NKTR

Simply Wall St.

5 months ago

Nektar Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus

NKTR

Zacks

5 months ago

Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus

NKTR

GuruFocus.com

5 months ago

Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Outlook

NKTR

Zacks

5 months ago

Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates

NKTR

Associated Press Finance

5 months ago

Nektar: Q3 Earnings Snapshot

Nektar Therapeutics Reports Third Quarter 2024 Financial Results

NKTR

PR Newswire

5 months ago

Nektar Therapeutics Reports Third Quarter 2024 Financial Results

NKTR

MT Newswires

5 months ago

Nektar Therapeutics Says NKTR-255 Boosts Immune Recovery After Radiation Therapy

NKTR

PR Newswire

5 months ago

Nektar and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 for the Treatment of Radiation Induced Lymphopenia in Locally Advanced Non-Small Cell Lung Cancer Patients at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Nektar Therapeutics to Participate in Upcoming Investor Conferences

NKTR

PR Newswire

5 months ago

Nektar Therapeutics to Participate in Upcoming Investor Conferences

Nektar Therapeutics to sell Alabama facility to Ampersand

NKTR

Pharmaceutical Technology

5 months ago

Nektar Therapeutics to sell Alabama facility to Ampersand

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential

NKTR

Benzinga

5 months ago

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential

NKTR

MT Newswires

5 months ago

Nektar Therapeutics Shares Rise After Deal to Sell Alabama Facility, PEGylation Business for $90 Million

Nektar Announces Definitive Agreement with Ampersand Capital Partners to Sell Its Commercial PEGylation Reagent Manufacturing Business in Alabama

NKTR

PR Newswire

5 months ago

Nektar Announces Definitive Agreement with Ampersand Capital Partners to Sell Its Commercial PEGylation Reagent Manufacturing Business in Alabama

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

NKTR

PR Newswire

6 months ago

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets

Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases

NKTR

PR Newswire

6 months ago

Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases

NKTR

MT Newswires

6 months ago

Nektar Therapeutics Up After Leukemia Candidate Found Beneficial in Early-Stage Study

NKTR

PR Newswire

6 months ago

Nektar Announces Publication in Blood of Phase 1 Data for Novel IL-15 Agonist NKTR-255 in Combination with Autologous CD19-22 CAR-T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024

NKTR

PR Newswire

7 months ago

Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024

Why Is Esperion Therapeutics (ESPR) Down 3.9% Since Last Earnings Report?

NKTR

Zacks

7 months ago

Why Is Esperion Therapeutics (ESPR) Down 3.9% Since Last Earnings Report?

Nektar Management to Present at Upcoming Investor Conferences

NKTR

PR Newswire

8 months ago

Nektar Management to Present at Upcoming Investor Conferences

NKTR

Zacks

8 months ago

What Makes Nektar (NKTR) a New Buy Stock

Nektar Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

NKTR

Simply Wall St.

8 months ago

Nektar Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

NKTR

Zacks

8 months ago

Nektar's (NKTR) Q2 Earnings Lag Estimates, Revenues Top

NKTR

Zacks

8 months ago

Nektar Therapeutics (NKTR) Reports Q2 Loss, Tops Revenue Estimates

NKTR

Associated Press Finance

8 months ago

Nektar: Q2 Earnings Snapshot

Nektar Therapeutics Reports Second Quarter 2024 Financial Results

NKTR

PR Newswire

8 months ago

Nektar Therapeutics Reports Second Quarter 2024 Financial Results

Nektar to Announce Financial Results for the Second Quarter 2024 on Thursday, August 8, 2024, After Close of U.S.-Based Financial Markets

NKTR

PR Newswire

9 months ago

Nektar to Announce Financial Results for the Second Quarter 2024 on Thursday, August 8, 2024, After Close of U.S.-Based Financial Markets

NKTR

Simply Wall St.

9 months ago

Nektar Therapeutics' (NASDAQ:NKTR) large institutional owners must be happy as stock continues to impress, up 13% over the past week

NKTR

PR Newswire

10 months ago

Nektar Therapeutics Presents First Preclinical Data on NKTR-0165, a TNFR2 Agonist Antibody Being Developed for the Treatment of Inflammatory Diseases, at EULAR 2024

Italian energy company targets Britain for fleet of 20 mini-nukes

NKTR

The Telegraph

10 months ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

NKTR

Simply Wall St.

10 months ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

NKTR

Simply Wall St.

10 months ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

NKTR

Simply Wall St.

10 months ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

NKTR

Motley Fool

10 months ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

NKTR

Simply Wall St.

10 months ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

NKTR

Simply Wall St.

10 months ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Seoul resumes loudspeaker propaganda against North

NKTR

AFP

10 months ago

Seoul resumes loudspeaker propaganda against North

NKTR

Simply Wall St.

10 months ago

Nektar Therapeutics' (NASDAQ:NKTR) investors will be pleased with their stellar 130% return over the last year

NKTR

PR Newswire

a year ago

Nektar Management to Present at Upcoming Investor Conferences

NKTR

Insider Monkey

a year ago

Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript

NKTR

GuruFocus.com

a year ago

Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview

NKTR

Zacks

a year ago

Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates

NKTR

Thomson Reuters StreetEvents

a year ago

Q1 2024 Nektar Therapeutics Earnings Call

NKTR

Associated Press Finance

a year ago

Nektar: Q1 Earnings Snapshot

Nektar Therapeutics Reports First Quarter 2024 Financial Results

NKTR

PR Newswire

a year ago

Nektar Therapeutics Reports First Quarter 2024 Financial Results

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets

NKTR

PR Newswire

a year ago

Nektar to Announce Financial Results for the First Quarter 2024 on Thursday, May 9, 2024, After Close of U.S.-Based Financial Markets

NKTR

Zacks

a year ago

Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?

Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference

NKTR

PR Newswire

a year ago

Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference

NKTR

Zacks

a year ago

Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata

NKTR

Zacks

a year ago

Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat

NKTR

Insider Monkey

a year ago

Nektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcript

Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata

NKTR

PR Newswire

a year ago

Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata

NKTR

Thomson Reuters StreetEvents

a year ago

Q4 2023 Nektar Therapeutics Earnings Call

NKTR

Zacks

a year ago

Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates

NKTR

GuruFocus.com

a year ago

Nektar Therapeutics (NKTR) Reports Fiscal Year-End and Q4 2023 Results

NKTR

Associated Press Finance

a year ago

Nektar: Q4 Earnings Snapshot

Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results

NKTR

PR Newswire

a year ago

Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results

Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX

NKTR

PR Newswire

a year ago

Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX

Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference

NKTR

PR Newswire

a year ago

Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference

Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets

NKTR

PR Newswire

a year ago

Latest Nektar Therapeutics (NKTR) News on April 19, 2025

Share on Social Networks: